News on the Division of Blood Diseases and Resources
|
News Release
NIH study finds lung function remained stable or improved in adults after transplant So-called low-intensity blood stem cell transplants, which use milder conditioning agents than standard stem cell transplants, do not appear to damage the lungs and may help improve lung function in some patients with sickle cell disease (SCD), according to a three...
|
NHLBI in the Press
Everyone responds to exercise differently. Now, researchers are reporting an advance toward a blood test that can help predict an individual’s best exercise choice for optimizing cardiorespiratory fitness.
|
NHLBI in the Press
Researchers are reporting new insights into a mysterious post-COVID illness called multisystem inflammatory syndrome in adults, or MIS-A.
|
NHLBI in the Press
The National Institutes of Health has halted a clinical trial evaluating the safety and effectiveness of COVID-19 convalescent plasma in treating emergency department patients who developed mild to moderate symptoms of COVID-19, the disease caused by the coronavirus SARS-CoV-2.
Credit:
Stephanie King, University of Michigan
|
NHLBI in the Press
NHLBI-supported researchers are reporting that COVID-19 triggers the production of certain autoimmune antibodies in the blood and that these antibodies are the culprit behind the formation of potentially life-threating blood clots in people hospitalized with the disease.
Credit:
NIH Medical Arts
|
NHLBI in the Press
Researchers at the National Institutes of Health have discovered a biological pathway that the novel coronavirus appears to use to hijack and exit cells as it spreads through the body.
|
NHLBI in the Press
Researchers are reporting that patients who had the most severe COVID-19 may be the best donors of convalescent plasma that is increasingly used to treat the disease.